X
New research from BenovelentAI supports use of Lilly’s Olumiant in COVID-19
https://pharmaphorum.com/news/new-research-from-benovelentai-supports-use-of-lillys-olumiant-in-covid-19/
BenevolentAI
Budget 2017: Artificial Intelligence funds welcome, but bolder vision needed
UK AI leader welcomes increased investment but suggests more needs to be done.
AI-discovered candidates show promise in ALS
Candidates slow down motor neurone death in patient samples.
BenevolentAI to power small molecule drug discovery
Deal with MRCT will look for potential new drug targets and candidates.
Janssen licenses drugs to artificial intelligence company
BenevolentAI’s Judgment Augmented Cognition System will help develop the new drugs.